2019
DOI: 10.1002/adsc.201900380
|View full text |Cite
|
Sign up to set email alerts
|

Rhodium‐Catalyzed Asymmetric [2+2+2] Cycloaddition Reactions of 1,6‐Enynes and Oxabenzonorbornadienes

Abstract: The asymmetric [2 + 2 + 2] cycloaddition reactions of 1,6-enynes and oxabenzonorbornadienes was accomplished by using the complex of [Rh(COD) 2 ]BF 4 and (R)-Xyl-P-Phos as chiral catalyst. A range of 1,6-enynes and oxabenzonorbornadienes were well tolerated in the cycloaddition reaction, which afforded various polycyclic products with asymmetric quaternary carbon centers generally in excellent enantioselectivities.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 33 publications
0
9
0
Order By: Relevance
“…In 2019, Fan, Zhou, and co-workers established the Rhcatalyzed asymmetric [2+2+2] cycloaddition of 1,6-enynes and oxabenzonorbornadienes to access polycyclic compounds in 12-66% yield and 60-99% ee (Scheme 35). 97 The reaction was carried out in the presence of [Rh(cod) 2 ]BF 4 (0.5 mol%) as the rhodium precursor and (R)-Xyl-P-Phos as a ligand in 1,4-dioxane at 40 °C, and delivered a range of polycyclic cycloadducts bearing quaternary stereocenters. 1,6-Enynes having a nitrogen-or oxygen-tether were well tolerated whereas reactions with a carbon-linked 1,6-enyne or 1,7-enyne failed to afford the expected cycloadducts, and the use of internal alkynes and alkenes led to lower yields.…”
Section: Scheme 34mentioning
confidence: 99%
“…In 2019, Fan, Zhou, and co-workers established the Rhcatalyzed asymmetric [2+2+2] cycloaddition of 1,6-enynes and oxabenzonorbornadienes to access polycyclic compounds in 12-66% yield and 60-99% ee (Scheme 35). 97 The reaction was carried out in the presence of [Rh(cod) 2 ]BF 4 (0.5 mol%) as the rhodium precursor and (R)-Xyl-P-Phos as a ligand in 1,4-dioxane at 40 °C, and delivered a range of polycyclic cycloadducts bearing quaternary stereocenters. 1,6-Enynes having a nitrogen-or oxygen-tether were well tolerated whereas reactions with a carbon-linked 1,6-enyne or 1,7-enyne failed to afford the expected cycloadducts, and the use of internal alkynes and alkenes led to lower yields.…”
Section: Scheme 34mentioning
confidence: 99%
“…Recently, we have demonstrated the first example of asymmetric [2+2+2] cycloaddition reactions of 1,6‐enynes 95 with oxabenzonorbornadienes . The reaction proceeded under the catalytic system of [Rh(cod) 2 ]BF 4 and ( R )‐Xyl‐P‐Phos, affording various polycyclic products 96 with quaternary carbon centers in excellent enantioselectivities [Eq.…”
Section: Cycloaddition Reactions Of Norbornadienes With Alkynesmentioning
confidence: 99%
“…The reaction between these substrates also provided a convenient synthetic route to benzocoumarin derivatives which are electron‐transporting emitters . The synthetic application of the reaction between these two substrates was again demonstrated in the synthesis of 3a,9b‐dihydrobenzo[ g ]indoles which were further converted to benzo[ g ]indoles . The naphthofuran skeleton which is found in various natural products was successfully synthesized from these substrates .…”
Section: Synthetic Applications Of Reactions Between Norbornadienes Amentioning
confidence: 99%
“…12 Following this, our group developed the first Rh-catalyzed asymmetric [2 + 2 + 2] cycloaddition reaction of a wide range of 1,6-enynes with oxabicyclic alkenes which afforded various polycyclic products that contain asymmetric quaternary carbon centers with excellent enantioselectivity. 13 We have also reported an efficient cobalt-catalyzed reaction of 1,6-enynes and thiols for the synthesis of different carbocyclic organosulfur compounds based on the ligands used. 14 Chalcones which consist of an enone carbonyl group are important frameworks with significant biological activities such as anticancer, anti-HIV, anti-inflammatory, etc.…”
Section: Introductionmentioning
confidence: 99%